$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Diet taboos and life precautions while taking Rasagiline
2026-02-01 22:25:32
Check Details
FDA approves expanded application of Jivi to benefit children over 7 years old with hemophilia A
2026-02-01 22:25:32
Check Details
Phase 3 trial of CTx-1301 releases positive data, helping to achieve new breakthroughs in the treatment of children with ADHD
2026-02-01 22:25:32
Check Details
The mechanism of action and efficacy of Teclistamab-cqyv
2026-02-01 22:25:32
Check Details
What are the specific specifications of Quizartinib?
2026-02-01 22:25:32
Check Details
What is the therapeutic effect of pomalidomide and is there any clinical feedback?
2026-02-01 22:25:32
Check Details
What is the relationship between the main effects of lapatinib and its market price?
2026-02-01 22:25:32
Check Details
Introduction to the functions and uses of filgotinib
2026-02-01 22:25:32
Check Details
Trientine manufacturer and drug source
2026-02-01 22:25:32
Check Details
Bosutinib/bosutinib dosage guidelines and precautions
2026-02-01 22:25:32
Check Details
What are the specific usage, dosage and course of treatment of Milizumab?
2026-02-01 22:25:32
Check Details
Which manufacturer is responsible for producing selumetinib?
2026-02-01 22:25:32
Check Details
1
2
...
1646
1647
1648
1649
1650
1651
1652
...
10226
10227
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained
2
Asciminib (SCEMBLIX): STAMP Inhibitor Dosing Guide and Nomenclature Clarification for CML
3
Belzutifan (Welireg): HIF-2α Inhibitor for VHL-Associated Tumors and Renal Cell Carcinoma — Dosing Phases, Survival Data, and Efficacy Insights
4
Cabergoline Medication Guide: Contraindications, Treatment Costs, and Safety Monitoring Essentials
5
Pemigatinib vs. Anlotinib: Key Differences Between FGFR-Targeted Therapy and Multi-Target Anti-Angiogenic Treatment
6
Enasidenib (IDHIFA): A Comprehensive Guide to Targeted Therapy for IDH2-Mutated Acute Myeloid Leukemia
7
Midostaurin vs. Gilteritinib: Key Differences in FLT3-Targeted AML Therapy
8
Lapatinib: A Targeted Anticancer Agent — Not Merely Symptom Relief
9
Filgotinib: Mechanism of Action and Clinical Applications Explained
10
Lapatinib: Proper Administration Guide and Key Precautions
11
Capivasertib (Truqap) Complete Medication Guide: Indications, Dosing, Safety, and Precautions
12
Cemiplimab Storage and Handling Guide